The biotech is now banking on secondary data signals as it progresses ignaseclant to late-stage trials in Charcot-Marie-Tooth ...
A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. | A phase 2a trial of NMD ...
Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and ...
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited neuromuscular disorder affecting 9.7-82 ...
9-1-1: Nashville star Isabelle Tate’s death is bringing attention to a rare disease. On Thursday, October 23, news broke that the actress had died at the age of 23. Her agency confirmed the news via ...
Hosted on MSN
Isabelle Tate Death: What Is Charcot-Marie-Tooth Disease, The Rare Disorder '911 Nashville' Actress Lived With?
Actress Isabelle Tate, who appeared as Julie in ABC’s 9-1-1: Nashville, tragically passed away at the age of 23 on October 19, 2025. Tate had a rare form of Charcot-Marie-Tooth disease (CMT), a ...
When legendary country singer Alan Jackson, 67, announced that the "finale" show of his farewell tour next year will support research to find a cure for Charcot-Marie-Tooth (CMT) disease, it shined a ...
(Reuters) - Using technology gleaned from the mapping of the human genome, privately held French drug developer Pharnext SAS is a step closer to providing a treatment for a rare neurological disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results